Observational Study on Disease Progress and Quality of Life in Adults with Sleep Disorders Including Narcolepsy and Other Neurological Conditions

What this Trial Is About

This observational study focuses on patients with sleep disorders treated at the Mainz Comprehensive Epilepsy and Sleep Medicine Center. It aims to understand the course of these diseases and their impact on quality of life by collecting both retrospective clinical data and prospective quality of life information. The study includes various sleep conditions such as narcolepsy, sleep apnea, insomnia, restless legs syndrome, and others. Participants include patients with narcolepsy and other neurological sleep disorders, some of whom may be treated with vagus nerve stimulation. The study observes patients with and without narcolepsy who have received this device treatment but does not involve any additional interventions. Data collection covers clinical history, prior medication use, and disease severity. During the study, patients will complete assessments measuring daytime sleepiness, quality of life, fatigue, depression, resilience, sleep quality, and social support at multiple time points including 3, 6, and 12 months. These evaluations use tools such as the Epworth Sleepiness Scale, Beck Depression Inventory, and Pittsburgh Sleep Quality Index. The study monitors these outcomes to better understand the disease progression and patient experience over time.

Mainz Register of Patients With Sleep Disorders